Farhan Hamid, 41, has been in intensive care at Manchester Royal Infirmary taking part in a trial of Otilimab, a rheumatoid arthritis drug that could help ease the effects of Covid-19.
Etiam at libero iaculis, mollis justo non, blandit augue. Vestibulum sit amet sodales est, a lacinia ex. Suspendisse vel enim sagittis, volutpat sem eget, condimentum sem.
0 comments: